NorthWest Biotherapeutics Inc (NWBO)

[Pharmboy46]

I’m in the boat that believes that the publication, buildout for production and the approval process are going on simultaneously. Like many have stated before me, what good would it do for them to come out with a “partial TLD” statement that would surely draw criticism from anyone demanding more than just a basic picture? Publishing a scientifically reviewed article in a respected journal takes time and leaves a lot of the time consuming steps in other’s hands (reviewers, publishers etc) but may be a far superior way to reveal their findings.
Also a better option for shareholders because it would presumably offer a more sustained, higher share price.
One could also argue that leaving a protracted amount of time between TLD and approval may not serve shareholders as it may create another “quiet period” which many would find unacceptable!